MICHAEL WOLINSKI: Open Payments
NPI 1013776673 · BANNOCKBURN, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,163 in 49 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $445 · 2025 $1,163
Food & beverage: $1,163
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 17 | $372 |
| AstraZeneca Pharmaceuticals LP | 7 | $151 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $129 |
| Novo Nordisk Inc | 1 | $120 |
| PFIZER INC. | 5 | $115 |
| Janssen Pharmaceuticals, Inc | 3 | $62 |
| E.R. Squibb & Sons, L.L.C. | 3 | $54 |
| Alnylam Pharmaceuticals Inc. | 2 | $51 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $31 |
| Ionis Pharmaceuticals, Inc. | 1 | $24 |
Products named: LEQVIO, FARXIGA, JARDIANCE, Wegovy, ELIQUIS, VYNDAQEL, ONPATTRO, OPSYNVI.
Industry payments across IL — which companies pay providers there.
